Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
At most synapses, chemical signalling is terminated by a rapid reaccumulation of neurotransmitter into presynaptic terminals. Uptake systems for the biogenic amines are the initial site of action for therapeutic antidepressants and drugs such as cocaine and the amphetamines. We have isolated a complementary DNA clone encoding a human noradrenaline transporter. The cDNA sequence predicts a protein of 617 amino acids, with 12-13 highly hydrophobic regions compatible with membrane-spanning domains. Expression of the cDNA clone in transfected HeLa cells indicates that noradrenaline transport activity is sodium-dependent and sensitive to selective noradrenaline transport inhibitors. Transporter RNA is localized to the brainstem and the adrenal gland. The predicted protein sequence demonstrates significant amino-acid identity with the Na+/gamma-aminobutyric acid transporter, thus identifying a new gene family for neurotransmitter transporter proteins. Analysis of its structure and function may lead to structure-based drug design for the treatment of human depression and could help determine whether transporter abnormalities underlie affective disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Direct sequence analysis of the norepinephrinetransporter gene in the proband revealed no divergence from previously published sequences 14,18 in exons 1 through 8 and exons 10 through 15.”
From Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency (2000) · cites this paper as [14]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,843
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Patterns of Amino Acids near Signal‐Sequence Cleavage Sites
VON HEIJNE, G. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07424.x · Cited by 2,280
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
Research works printed but not linked: 6
- Snyder, S. H. Biol. Psychiat. 2, 367–389 (1970).
- Biedler, J. L., Helson, L. & Spengler, B. A. Cancer Res. 33, 2643–2652 (1973).
- Buck, J., Bruchelt, G., Girgert, R., Treuner, J. & Niethammer, D. Cancer Res. 45, 6366–6370 (1985).
- Smets, L. A., Loesberg, C., Janssen, M., Metwally, E. A. & Huiskamp, R. Cancer Res. 49, 2941–2944 (1989).
- Javitch, J. A., Blaustein, R. O. & Snyder, S. H. Molec. Pharmacol. 26, 35–44 (1984).
- Kostrzewa, R. M. & Jacobowitz, D. M. Pharmac. Rev. 26, 199–288 (1974).
Cited by
Items 401–500 of 1,000
Ethanol-sensitive Sites on the Human Dopamine Transporter
Maiya, R., Buck, K. J., Harris, R. A., & Mayfield, R. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204914200 · Cited by 43
Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells
Streich, S., Miss, M.-T., & B�nisch, H. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168636 · Cited by 43
Kaye, D. M., Gruskin, S., Smith, A. I., & Esler, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703416 · Cited by 43
“…(sense2) 5'-CTGCCTTACTTGTGCTGT TCG-3', (antisense2) 5'-CCTGTGACCTGGACATTGGCA TGG, and which correspond to bp 734 to 710, bp +1250 to +1271, bp +865 to 886 and bp +1942 to +1965 of a human norepinephrine transporter (hNET) previously identi®ed in neuroblastoma cells (Pacholyczyk et al., 1991).”
BackgroundCellular and Molecular Aspects of Monoamine Neurotransmitter Transporters
Kitayama, S., & Dohi, T. (1996) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.72.195 · Cited by 43
Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone
Martel, F., Ribeiro, L. V. P. T., Calhau, C., & Azevedo, I. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005356 · Cited by 43
“The human and bovine uptake1 transporters have been cloned ( Pacholczyk et al. 1991; Lingen et al. 1994).”
BackgroundBurgess, K. S. D., & Justice, J. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730656.x · Cited by 42
“In the past few years, molecular cloning of the NET and DAT has revealed their amino acid sequences and the presence of 12 putative transmembrane (TM) spanning domains (Giros et al., 1991, 1992; Kilty et al., 1991; Pacholczyk et al., 1991; Shimada et al., 1991; Usdin et al., 1991).”
BackgroundDodd, J. R., Zheng, T., & Christie, D. L. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00113-0 · Cited by 42
A neurotransmitter transporter encoded by the Drosophila inebriated gene
Soehnge, H., Huang, X., Becker, M. N., Whitley, P., Conover, D., & Stern, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13262 · Cited by 42
Seitz, G., Stegmann, H. B., Jäger, H. H., Schlude, H. M., Wolburg, H., Roginsky, V. A., Niethammer, D., & Bruchelt, G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750511.x · Cited by 42
Growth factor action in neural crest cell diversification
Sieber‐Blum, M., & Zhang, J. M. (1997) · Journal of Anatomy · doi:10.1046/j.1469-7580.1997.19140493.x · Cited by 42
Savchenko, V. L., Sung, U., & Blakely, R. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00235-5 · Cited by 42
Self-citationRelease-regulating presynaptic heterocarriers
Bonanno, G., & Raiteri, M. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90006-x · Cited by 42
Gu, H. H., Wu, X., Giros, B., Caron, M. G., Caplan, M. J., & Rudnick, G. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.12.3797 · Cited by 41
“Like other members of this family, the biogenic amine transporters, including dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT), were predicted from hydropathy analysis to contain 12 transmembrane domains with cytoplasmic NH2- and COOH-termini (Blakely et al., 1991; Giros e…”
BackgroundMethodInfluentialUchida, J., Kiuchi, Y., Ohno, M., Yura, A., & Oguchi, K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00850-6 · Cited by 41
Bian, X., Zhu, J., Jia, X., Liang, W., Yu, S., Li, Z., Zhang, W., & Rao, Y. (2023) · eLife · doi:10.7554/elife.89317 · Cited by 40
“It is notable that SLC6A8 belongs to the NTT family, with multiple members already shown to transport neurotransmitters ( Pacholczyk et al., 1991 ; Blakely et al., 1991 ; Guastella et al., 1992 ; Clark et al., 1992 ; Borden et al., 1992 ; Lopez-Corcuera et al., 1992 ; Giros et al., 1991 ; Kilty et…”
BackgroundZheng, G., Yang, F., Fu, T., Tu, G., Chen, Y., Yao, X., Xue, W., & Zhu, F. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp06232c · Cited by 40
Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring
Shao, F., Long, Y., Ji, H., Jiang, D., Lei, P., & Lan, X. (2021) · Theranostics · doi:10.7150/thno.56989 · Cited by 40
“The advantage of hNET as a reporter is that its corresponding radiolabeled probe, metaiodobenzylguanidine (MIBG), is currently used in the clinic, and can be radiolabeled with 123I or 131I for SPECT and γ-camera imaging and with124I for PET imaging [119-121].”
BackgroundBURTON, D. L., KIPPENBERGER, G. A., Lingen, B., Brüss, M., Bönisch, H., & Christie, L. (1998) · Biochemical Journal · doi:10.1042/bj3300909 · Cited by 40
Placental biogenic amine transporters: cloning and expression
Padbury, J. F., Tseng, Y., McGonnigal, B., Penado, K. M. Y., Stephan, M. M., & Rudnick, G. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00309-9 · Cited by 40
Eisenhofer, G., McCarty, R. C., Pacák, K., Russ, H., Sch�mig, E., & Eisenhofer, G. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171059 · Cited by 40
“Several transporters for neuronal uptake have been cloned and structurally identified and these are widely believed to provide the primary means for terminating the actions of released catecholamines (Pacholczyk et al. 1991).”
BackgroundPifl, C., Agneter, E., Drobny, H., Reither, H., & Singer, E. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701137 · Cited by 40
“Unspeci®c uptake was determined in the presence of 10 mM mazindol, an uptake inhibitor with a Ki of 11 nM and 1.4 nM at the DAT (Giros et al., 1992) and NAT (Pacholczyk et al., 1991), respectively.”
MethodInfluentialPharmacological properties of naturally occurring variants of the human norepinephrine transporter.
Runkel, F., Brüss, M., Nöthen, M. M., Stöber, G., Propping, P., & Bönisch, H. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00003 · Cited by 40
Mosckovitz, R., Yan, N., Heimer, E. P., Felix, A. M., Tate, S. S., & Udenfriend, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4022 · Cited by 40
Sagata, K., Minami, K., Yanagihara, N., Shiraishi, M., Toyohira, Y., Ueno, S., & Shigematsu, A. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200204000-00024 · Cited by 39
Thakur, G. A., Sengupta, S. M., Grizenko, N., Choudhry, Z., & Joober, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049616 · Cited by 33
Phillips, J. K., Dubey, R., Sesiashvilvi, E., Takeda, M., Christie, D. L., & Lipski, J. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00113-7 · Cited by 39
Uys, J., & Niesink, R. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500295725 · Cited by 32
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)
Lazar, A., Gründemann, D., Berkels, R., Taubert, D., Zimmermann, T., & Schömig, E. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0015-5 · Cited by 39
“In addition to high-affinity low-capacity transport into releasing neurons (Pacholczyk et al. 1991), the inactivation of catecholamines is mediated by a lowaffinity high-capacity non-neuronal system, originally named uptake2 (Iversen 1965).”
BackgroundMahaney, P. E., Vu, A. T., McComas, C. C., Zhang, P., Nogle, L. M., Watts, W. L., Sarkahian, A., Leventhal, L., Sullivan, N. R., Uveges, A. J., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.039 · Cited by 39
Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes
Benesics, A., Sershen, H. W., Baranyi, M., Hashim, A., Lajtha, Á., & Vizi, E. S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00313-2 · Cited by 39
Sodium-dependent neurotransmitter reuptake systems
Amara, S., & Pacholczyk, T. (1991) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(91)90014-x · Cited by 39
Self-citationSzot, P., White, S. S., & Veith, R. C. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00217-3 · Cited by 39
Luca, V. D., Muglia, P., Jain, U., & Kennedy, J. L. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20075 · Cited by 39
“NET protein is ubiquitously expressed in the brain as well as outside the CNS, in the adrenal glands [Pacholczyk et al., 1991], possesses 12 transmembrane domains (TMDs) and it is involved in the termination of synaptic transmission by rapid reaccumulation of noradrenaline into presynaptic…”
BackgroundSandhu, S. K., Ross, L. S., & Gill, S. S. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03084.x · Cited by 39
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology
Fairweather, S. J., Shah, N., & Bröer, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_584 · Cited by 38
Rab11 Supports Amphetamine-Stimulated Norepinephrine Transporter Trafficking
Matthies, H. J. G., Moore, J. L., Saunders, C., Matthies, D. S., Lapierre, L. A., Goldenring, J. R., Blakely, R., & Galli, A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4574-09.2010 · Cited by 38
“The norepinephrine transporter (NET) is a presynaptic plasma membrane protein with a critical role in the reuptake of released norepinephrine (NE) (Iversen, 1971; Pacholczyk et al., 1991; Bonisch and Bruss, 2006).”
BackgroundSelf-citationProtective Effect of Talipexole on MPTP-Treated Planarian, a Unique Parkinsonian Worm Model
Yoshihisa, K., Kakimura, J., & Takashi, T. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.78.23 · Cited by 38
Bzoskie, L., Yen, J., Tseng, Y. T., Blount, L., Kashiwai, K., & Padbury, J. F. (1997) · Placenta · doi:10.1016/s0143-4004(97)90094-1 · Cited by 38
Putative drug binding conformations of monoamine transporters
Ravna, A. W., Sylte, I., Kristiansen, K., & Dahl, S. G. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.054 · Cited by 38
Presynaptic events involved in neurotransmission
Nelson, N. (1993) · Journal of Physiology-Paris · doi:10.1016/0928-4257(93)90028-r · Cited by 38
Okada, T., Fujita, M., Shimada, S., Sato, K., Schloss, P. D., Watanabe, Y., Itoh, Y., Tohyama, M., & Nishimura, T. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00156-x · Cited by 38
Sung, U., Jennings, J. L., Link, A. J., & Blakely, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.165 · Cited by 37
Self-citationCalcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A.
Sung, U., & Blakely, R. (2007) · Molecular and cellular neurosciences · doi:10.1016/j.mcn.2006.11.007 · Cited by 36
“Presynaptic norepinephrine (NE) transporters (NET, SLC6A2) terminate NE signals at central and peripheral synapses through Na+ and Cl− mediated neurotransmitter reuptake (Pacholczyk et al., 1991).”
BackgroundSelf-citationCollado, V., Hennèquin, M., Faulks, D., Mazille, M.-N., Nicolas, E., Koscielny, S., & Onody, P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000236660.01039.eb · Cited by 38
Bayer, M., Kuçi, Z., Schömig, E., Gründemann, D., Dittmann, H., Handgretinger, R., & Bruchelt, G. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.12.010 · Cited by 37
Meco, D., Lasorella, A., Riccardi, A., Servidei, T., Mastrangelo, R., & Riccardi, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00078-7 · Cited by 37
Molecular cloning of an orphan transporter A new member of the neurotransmitter transporter family
Smith, K. E., Fried, S. G., Durkin, M. M., Gustafson, E. L., Borden, L. A., Branchek, T. A., & Weinshank, R. L. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01328-x · Cited by 37
López‐Corcuera, B., Alcántara, R., Vázquez, J., & Aragón, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53987-9 · Cited by 37
Clark, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14695 · Cited by 37
Zeng, F., Mun, J.-Y., Jarkas, N., Stehouwer, J. S., Voll, R. J., Tamagnan, G. D., Howell, L. L., Votaw, J. R., Kilts, C. D., Nemeroff, C. B., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800817h · Cited by 36
“Consequently, fluoroethyl derivative (2) and fluoropropyl derivative (3) bind to the NET and SERT with approximately the same affinity, which is three to five times lower than that for 1, respectively.”
BackgroundFunctionally distinct dopamine and octopamine transporters in the CNS of the cabbage looper moth*
Gallant, P., Malutan, T., McLean, H., Verellen, L., Caveney, S., & Donly, C. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03417.x · Cited by 36
New views of biogenic amine transporter function: implications for neuropsychopharmacology
Frazer, A., Gerhardt, G. A., & Daws, L. C. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001625 · Cited by 36
“The cloning of these biogenic amine transporters in the early 1990s (Blakely et al., 1991 ; Giros and Caron, 1993 ; Hoffman et al., 1991 ; Pacholczyk et al., 1991) and the development of selective radioligands for them at about the same time permitted a range of studies not previously possible.”
BackgroundMolecular characterization of neurotransmitter transporters
Shafqat, S., Velaz-Faircloth, M., Guadaño‐Ferraz, A., & Fremeau, R. T. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.12.7908408 · Cited by 36
Li, N., Li, C., Han, R., Wang, Y., Yang, M., Wang, H., & Tian, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00053 · Cited by 35
Regulation of Rat Dopamine Transporter mRNA and Protein by Chronic Cocaine Administration
Letchworth, S. R., Sexton, T., Childers, S. R., Vrana, K. E., Vaughan, R. A., Davies, H. M. L., & Porrino, L. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.01982.x · Cited by 35
“This is a sequence from a non–membrane-spanning region that has low homology to other monoamine transporters (Hoffman et al., 1991; Pacholczyk et al., 1991).”
BackgroundHuman placenta: A direct target for cocaine action
Ganapathy, V., & Leibach, F. H. (1994) · Placenta · doi:10.1016/s0143-4004(05)80181-x · Cited by 35
Münch, G., Rosport, K., Bültmann, A., Baumgartner, C., Li, Z., Laacke, L., & Ungerer, M. (2005) · Circulation Research · doi:10.1161/01.res.0000186685.46829.e5 · Cited by 35
Kanner, B. I., Bendahan, A., Pantanowitz, S., & Su, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01255-5 · Cited by 35
Wakade, A. R., Wakade, T. D., Poosch, M. S., & Bannon, M. J. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021476 · Cited by 35
[3H]Nisoxetine binding sites in the cat brain: An autoradiographic study
Charnay, Y., Léger, L., Vallet, P. G., Hof, P. R., Jouvet, M., & Bouras, C. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00257-j · Cited by 35
Colocalization of dopamine and serotonin in the rat pituitary gland and in the nuclei innervating it
Vanhatalo, S., Soinila, S. O., Kaartinen, K., & Bäck, N. (1995) · Brain Research · doi:10.1016/0006-8993(94)01276-n · Cited by 35
Matsubara, K., Senda, T., Uezono, T., Fukushima, S., Ohta, S., Igarashi, K., Naoi, M., Yamashita, Y., Ohtaki, K., Hayase, N., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00131-9 · Cited by 35
Substrate binding and inhibition mechanism of norepinephrine transporter
Ji, W., Miao, A., Liang, K., Liu, J., Qi, Y., Zhou, Y., Duan, X., Sun, J., Lai, L., & Wu, J.-X. (2024) · Nature · doi:10.1038/s41586-024-07810-5 · Cited by 34
Epidemiological Evidence of an Association between SLC6A2 Gene Polymorphism and Hypertension
Ono, K., Iwanaga, Y., Mannami, T., Kokubo, Y., Tomoike, H., Komamura, K., Shioji, K., Yasui, N., Tago, N., & Iwai, N. (2003) · Hypertension Research · doi:10.1291/hypres.26.685 · Cited by 34
Wake-Promoting Medications: Basic Mechanisms and Pharmacology
Nishino, S., & Mignot, E. J.-M. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50045-8 · Cited by 34
Chapter 18: Regulation of the synthesis of acetylcholine
Rylett, R. J., & Schmidt, B. M. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62394-8 · Cited by 34
[24] Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins
Ramamoorthy, S., Melikian, H. E., Qian, Y., & Blakely, R. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)96026-8 · Cited by 34
Self-citationDesipramine-induced increase in norepinephrine transporter mRNA is not mediated via α2 receptors
Shores, M. M., Szot, P., & Veith, R. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90020-5 · Cited by 34
Zhang, J., Dix, J., Langtimm, C. J., Trusk, T. C., Schroeder, B., Hoffmann, R. G., Strosberg, A. D., Winslow, J. W., & Sieber‐Blum, M. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199703)32:3<262::aid-neu2>3.0.co;2-5 · Cited by 34
Hughes, Z. A., & Stanford, S. C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701947 · Cited by 34
“Furthermore, Northern blot analysis of brain tissue has con®rmed that there are two mRNAs (5.8 and 3.6 kb) for noradrenaline transporters and it has been suggested that the 3.6-kb mRNA could encode a glial-speci®c protein (Pacholczyk et al., 1991).”
BackgroundInfluentialApparsundaram, S., Moore, K. R., Malone, M., Hartzell, H. C., & Blakely, R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02691.1997 · Cited by 34
“…(10 5 cells/well of 24-well plate) were infected with recombinant virus encoding T7 RNA polymerase (10 pfu/cell). f ET, hNET in pBluescript SKII Ϫ (Pacholczyk et al., 1991), or pBluescript SKII Ϫ DNA (0.1 g / well for f ET and 0.5 g / well for hNET) was transfected into virus-infected HeLa…”
InfluentialSelf-citationLesch, K., & Bengel, D. (1995) · CNS Drugs · doi:10.2165/00023210-199504040-00007 · Cited by 34
Stoffel, W., Sasse, J., Düker, M., Müller, R., Hofmann, K., Fink, T., & Lichter, P. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00424-3 · Cited by 33
Yoshimura, R., Yanagihara, N., Hara, K., Terao, T., Nakamura, J., Ueno, S., Toyohira, Y., Uezono, Y., Kaneko, S., Kawamura, M., et al. (2000) · Psychopharmacology · doi:10.1007/s002139900339 · Cited by 33
“The cloned cDNA for NA transporter predicts 12 hydrophobic segments that are likely to be transmembrane domains ( Pacholczyk et al. 1991; Lingen et al. 1994).”
BackgroundStructure-Function Relationships for Biogenic Amine Neurotransmitter Transporters
Chen, N., & Reith, M. E. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-158-9_3 · Cited by 33
Ad, D., Factor, M. I., Segal, O. L., Pavlova, E. V., Massino, Y. S., Smirnova, M. B., Абдуллаевна, Я. Д., Dmitriev, D. A., Kizim, E. A., Kolyaskina, G. I., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.12.019 · Cited by 32
Use of nitrous oxide and oxygen for conscious sedation to manage pain and anxiety.
Ryding, H. A., & Murphy, H. J. (2007) · PubMed · Cited by 32
Studies of translocation catalysis
Henderson, P. J. F. (1991) · Bioscience Reports · doi:10.1007/bf01130216 · Cited by 32
Murine serotonin transporter: sequence and localization to Chromosome 11
Gregor, P., Patel, A. P., Shimada, S., Lin, C.-L., Rochelle, J. M., Kitayama, S., Seldin, M. F., & Uhl, G. R. (1993) · Mammalian Genome · doi:10.1007/bf00417438 · Cited by 32
“1991) and shown to be members of the neurotransmitter transporter gene family (Guastella et al. 1990; Pacholczyk et al. 1991).”
BackgroundBrownstein, M., & Hoffman, B. J. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-571149-4.50006-4 · Cited by 32
Rutgers, M., Tytgat, G. A. M., Verwijs-Janssen, M., Buitfnhuis, C., Smets, L. A., & Voûte, P. A. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540221 · Cited by 32
Differential kinetics of [123I]?-CIT binding to dopamine and serotonin transporters
Fujita, M., Takatoku, K., Matoba, Y., Nishiura, M., Kobayashi, K., Inoue, O., & Nishimura, T. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01247372 · Cited by 32
“The prototype psychomotor stimulant drug of abuse, cocaine, inhibits the uptake of monoamines, that is, DA, 5-HT and norepinephrine (NE), by binding to DAT, 5HTT and the NE transporter [3-8].”
BackgroundMattsson, C., Svensson, P., & Sonesson, C. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.035 · Cited by 31
“Two compounds (16, 18) were further evaluated for their selectivity in competition binding assays by CEREP (Poitiers, France) for affinity to the serotonin type 1A receptor (5-HT1A) [46], serotonin type 2A receptor (5-HT2A) [47], adrenergic type 1 receptor (a1) [48], adrenergic type 2 receptor (a2) [49] and histaminer…”
MethodLiu, J., Hu, A.-N., Zan, J.-F., Wang, P., You, Q., & Tan, A. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7826769 · Cited by 31
“As shown in Figure 3, five targets including DAD1, GRIA2, MAOA, MAOB, and SLC6A3 were all found to be associated with Cocaine addiction, Amphetamine addiction, Dopaminergic synapse, and Alcoholism together, which could help speculate the pharmacokinetic synergistic effects among them.”
BackgroundCardiac studies with metaiodobenzylguanidine: a critique of methods and interpretation of results.
Glowniak, J. V. (1995) · PubMed · Cited by 31
Rogers, C., & Lemaire, S. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12352.x · Cited by 31
Friedgen, B., W�lfel, R., Russ, H., Sch�mig, E., & Graefe, K.-H. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171058 · Cited by 31
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
Sun, Z., Fan, Y., Zha, Q., & Zhu, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06587.x · Cited by 27
González, A. M., & Uhl, G. R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90233-x · Cited by 30
Szot, P., White, S. S., Veith, R. C., & Rasmussen, D. D. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199910000-00012 · Cited by 30
Malutan, T., McLean, H., Caveney, S., & Donly, C. (2002) · Insect Biochemistry and Molecular Biology · doi:10.1016/s0965-1748(01)00114-x · Cited by 30
Szot, P., Reigel, C. E., White, S. S., & Veith, R. C. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00184-2 · Cited by 30
Stjärne, L., Bao, J., Gonon, F., & Msghina, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90280-1 · Cited by 30
Endocrine Aspects of Cancer Gene Therapy
Barzon, L., Boscaro, M., & Palù, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0035 · Cited by 30
Miller, J. W., Kleven, D. T., Domin, B. A., & Fremeau, R. T. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-470-2_4 · Cited by 30
Development of imaging agents for the dopamine transporter
Carroll, F. I., Scheffel, U., Dannals, R. F., Boja, J. W., & Kuhar, M. J. (1995) · Medicinal Research Reviews · doi:10.1002/med.2610150503 · Cited by 30
Monoamine transporters in human endometrium and decidua
Hansson, S. R., Bottalico, B., Noskova, V., & Casslén, B. G. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn048 · Cited by 29
“Cocaine and amphetamine block the uptake of monoamines in a similar way to that of SSRI, leading to increased levels of extracellular monoamines.”
BackgroundMethodInfluentialAstroglial 5-HT2Breceptor in mood disorders
Peng, L., Song, D., Li, B., & Verkhratsky, A. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1458612 · Cited by 27
“dopamine; incidentally its affinity to dopamine is higher than to noradrenaline [13].”
BackgroundIn Vivo Cell Tracking Using PET: Opportunities and Challenges for Clinical Translation in Oncology
Lechermann, L. M., Lau, D., Attili, B. N. N. R., Aloj, L., & Gallagher, F. A. (2021) · Cancers · doi:10.3390/cancers13164042 · Cited by 29
“It mediates the transport of norepinephrine, dopamine, and epinephrine across the cell membrane [77].”
Background
Metadata
- Authors
- Pacholczyk, T., Blakely, R. D., & Amara, S. G.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1991-03-28
- Volume
- 350
- Issue
- 6316
- Pages
- 350-354
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1980253852
- Cited by
- 933
- References
- 37
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 16 · 2022: 5 · 2021: 18 · 2020: 7 · 2019: 12 · 2018: 7 · 2017: 6 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 22
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- norepinephrine transporter, cocaine sensitivity, antidepressants, neurotransmitter uptake, sodium-dependent transport, brainstem, adrenal gland, depression, structure-based drug design, mood disorders
- MeSH terms
- Adrenal Glands, Amino Acid Sequence, Animals, Antidepressive Agents, Base Sequence, Brain Stem, Carrier Proteins, Cell Line, Cloning, Molecular, Cocaine, DNA, HeLa Cells, Humans, Kinetics, Models, Molecular, Molecular Sequence Data, Norepinephrine, Protein Conformation, RNA, Messenger, Transfection, Open Reading Frames, Symporters, Norepinephrine Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.